Parexel has partnered with Microsoft to advance patient-centric technologies and help deliver on the promise of personalized medicine following a need for efficiency and innovation in drug development.
Evidera has expanded its patient-centered research services, the advancement of which will enable the introduction of better treatments, faster, says team VP.
TriNetX has completed a yearlong project to expand its space from 8,200 to a 20,000 square feet in response to industry demand for its clinical trial services.
Vince & Associates Clinical Research is conducting a Phase Ib alcohol interaction study of Amygdala Neurosciences’ ANS-6637 for the potential treatment of substance abuse.
Pharmaceutical companies are more likely than their suppliers to cite cost improvement over time as the most effective metric for measuring supplier performance, according to a recent report.
WuXi AppTec’s acquisition of ResearchPoint Global (RPG) follows the release of a new guideline that will enable Chinese companies to accept clinical trial data from other countries.
The VWR Science Portal provides customers with access to the Scientist.com supplier network, including more than 2,200 contract research organizations (CROs).
Clinical study database challenges are delaying clinical trial timelines as CROs and sponsors must manage an increasing variety of trial data, according to a recent study.
Researchers are creating a “roadmap” for nephrology clinical trial design, which stresses the role patients and their families can play in rare disease study design.
China has announced that it will now accept clinical trial data from other countries in a new guideline that aims to reform the management of clinical trials.
Gene therapy developers should start planning earlier, as EU GMO regulations are delaying clinical trial start-up across the bloc, according to a new expert position paper.
The new Princeton, NJ-based office is the result of a multimillion-dollar investment and continued growth driven by an increasing use of medical imaging in clinical research.
CTTI has released new recommendations that can be implemented by sponsors, CROs, and others, in order to decrease the number of ‘one and done’ clinical trial site investigators.
SynteractHCR has moved to a new 38,000 square foot facility in Carlsbad, CA as it looks to fill the mid-market CRO void created by recent consolidation, says CEO.
Niche, small-scale CROs can stand their own – despite a predicted increase in consolidation among small-sized contract services firms – says Clinical Trial Consultants (CTC) and data-focused Quanticate.
Cullinan Oncology has launched with $150m in funding, a focus on risk, and a business model through which it will rely on a global network of third-party vendors, says CEO.
To simplify the human biospecimens procurement process, the online marketplace for outsourced scientific services, Scientist.com, has teamed up with iSpecimen.
Clinical trial participants often misunderstand the differences between research and clinical care – a ‘longstanding problem’ that an enhanced informed consent process could diminish, says report.
Ergomed is bolstering its orphan drug development services with its acquisition of PSR Group BV in a deal worth up to €5.7m ($6.69m) – which will position the company to be a “global player” in the area, says CEO.
Lack of trust has become less of a barrier to clinical trial participation, though more work needs to be done as information access and service levels receive low marks in a recent survey.
Pharma and diagnostic partners will gain access to a human cancer biospecimens and clinical data from patients to power clinical and translational research, says CRO.
Better trial designs mean fewer failed studies, says a tech industry veteran who has set his sights on improving the clinical trial process with artificial intelligence.
mProve Health has partnered with Greenphire to provide payment solutions on its patient engagement app – bringing it one step closer to creating a mobile hub for all study services, says CEO.
The Switzerland-headquartered contract research organization (CRO) has opened offices in Taiwan following a string of investments in the Asia Pacific region.
The clinical research environment in Japan has evolved dramatically since Parexel first began operations in the country, says the CRO, who recently established an alliance with a local cancer institute.
Researchers conducting smoking cessation clinical trials should use biochemical measures to determine if participants have quit – as many falsely self-report, according to a recent study.
CTTI has released new evidence-based recommendations to enable sponsors and investigators to better plan for and make decisions about pregnancy testing in clinical trials.
Clinical trial exclusion criteria has increased nearly 60% over the last 30 years – and may decrease the likelihood of successful trial completion and generalizability of results, say researchers.
There are many opportunities in Asia Pacific for mid-sized CROs says PSI, after opening a new office in Seoul, South Korea in response to client requests.
AMRI has been acquired by a private equity firm and has already begun its search for “the next couple of acquisitions,” says its CEO – and the shopping list is long.
The mid-size contract research organization (CRO) sector continues to evolve and surprise experts with rich valuations – and what seems to be a never ending list of transactions.
Trial By Fire Solutions has released SimpleTrials 2.0, an upgraded version of its clinical trial management system (CTMS) with new features including site contracts and payments management.
